H. Dimai

R. Gasser, P. Pietschmann, B. Obermayer-Pietsch, 2014, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Alkaline phosphatase levels and osteoprogenitor cell numbers suggest bone formation may contribute to peak bone density differences between two inbred strains of mice.

L. Donahue, C. Rosen, H. Dimai, 1998, Bone.

Variable bone mass recovery in hyperthyroid bone disease after radioiodine therapy in postmenopausal patients.

A. Berghold, B. Obermayer-Pietsch, G. Leb, 2000, Maturitas.

[Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010].

P. Pietschmann, H. Resch, H. Dimai, 2010, Wiener Medizinische Wochenschrift.

Vitamin D status and its relationship with bone mineral density in a healthy Iranian population

B. Larijani, A. Keshtkar, H. Dimai, 2016, Revista brasileira de ortopedia.

Vitamin D status and its relationship with bone mineral density and parathyroid hormone in Southeast Asian adults with low bone density.

H. C. Hoeck, H. Dimai, M. Chandran, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group

M. Hiligsmann, O. Bruyère, P. Lips, 2022, Archives of Osteoporosis.

Population screening for fracture risk in postmenopausal women — a logical step in reducing the osteoporotic fracture burden?

M. Hiligsmann, O. Bruyère, P. Lips, 2022, Osteoporosis International.

Effects of Zinc on Human Skeletal Alkaline Phosphatase Activity In Vitro

H. Dimai, J. Farley, S. Hall, 1999, Calcified Tissue International.

Calcitonin Increases the Concentration of Insulin-Like Growth Factors in Serum-Free Cultures of Human Osteoblast-Line Cells

S. Mohan, H. Dimai, T. Pham, 2000, Calcified Tissue International.

Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial.

W. März, S. Pilz, C. Catena, 2017, Bone.

Mortality After Hip Fracture in Austria 2008–2011

J. Zwerina, D. Kritsch, O. Kimberger, 2014, Calcified Tissue International.

Atypical Femoral Fractures-Ongoing and History of Bone-Specific Therapy, Concomitant Diseases, Medications, and Survival.

A. Kaider, P. Pietschmann, H. Resch, 2016, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

C. Cooper, J. Reginster, R. Rizzoli, 2017, Osteoporosis International.

Plasma parathyroid hormone and cardiovascular disease in treatment‐naive patients with primary hyperparathyroidism: The EPATH trial

W. März, B. Pieske, S. Pilz, 2017, Journal of clinical hypertension.

Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial

W. März, F. Lang, B. Pieske, 2017, PloS one.

Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions.

H. Dimai, A. Fahrleitner-Pammer, 2022, Best practice & research. Clinical rheumatology.

Bone Loss in Patients with Untreated Chronic Obstructive Pulmonary Disease Is Mediated by an Increase in Bone Resorption Associated with Hypercapnia

K. Lau, G. Leb, H. Dimai, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[Position paper on medication-related osteonecrosis of the jaw (MRONJ)].

G. Santler, R. Gasser, H. Dimai, 2016, Wiener medizinische Wochenschrift.

Daily oral magnesium supplementation suppresses bone turnover in young adult males.

K. Lau, M. Wilders-Truschnig, H. Dimai, 1998, The Journal of clinical endocrinology and metabolism.

Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta

H. Resch, H. Dimai, R. Kocijan, 2013, Skeletal Radiology.

Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study

J. Zwerina, H. Dimai, K. Klaushofer, 2015, Osteoporosis International.

Usefulness of the trabecular bone score in maintenance dialysis patients

T. Pieber, B. Obermayer-Pietsch, H. Dimai, 2022, Wiener klinische Wochenschrift.

Population screening for fracture risk in postmenopausal women — a logical step in reducing the osteoporotic fracture burden?

M. Hiligsmann, O. Bruyère, P. Lips, 2022, Osteoporosis International.

Pelvic Fractures—An Underestimated Problem? Incidence and Mortality Risk after Pelvic Fracture in Austria, 2010–2018

J. Zwerina, H. Resch, H. Dimai, 2022, Journal of Clinical Medicine.

Teaching first-year medical students in basic clinical and procedural skills − A novel course concept at a medical school in Austria

H. Dimai, L. Mileder, T. Wegscheider, 2014, GMS Zeitschrift fur medizinische Ausbildung.

[Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].

P. Pietschmann, H. Resch, H. Dimai, 2009, Wiener medizinische Wochenschrift. Supplement.

Osteoclast Formation in Bone Marrow Cultures from Two Inbred Strains of Mice with Different Bone Densities

L. Donahue, J. Wergedal, C. Rosen, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Low bone turnover and increase of bone mineral density in a premenopausal woman with postoperative hypoparathyroidism and thyroxine suppressive therapy

H. Dimai, A. Fahrleitner-Pammer, K. Amrein, 2011, Osteoporosis International.

Medical University admission test: a confirmatory factor analysis of the results

G. Reibnegger, H. Dimai, D. Ithaler, 2016, Wiener klinische Wochenschrift.

Bone - a casualty of ICU survival?

H. Dimai, A. Fahrleitner-Pammer, K. Amrein, 2015, Critical Care.

The effects of chronic hypobaric conditions

H. Dimai, 2005, Wiener Medizinische Wochenschrift.

Physical Activity is Superior to Body Mass Index in Modulating Bone Mineral Density in Healthy Adults

P. Zysset, E. Dall’Ara, P. Pietschmann, 2019 .

Osteoporosis treatment in Austria—assessment of FRAX-based intervention thresholds for high and very high fracture risk

J. Kanis, E. McCloskey, M. Lorentzon, 2022, Archives of Osteoporosis.

Prescreening for Osteoporosis With Quantitative Ultrasound in Postmenopausal White Women

H. Dimai, A. Fahrleitner-Pammer, Bernhard Steiner, 2018, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Pre-screening for Osteoporosis with Quantitative Ultrasound in Postmenopausal Caucasian Women

H. Dimai, Bernhard Steiner, Hubert Steiner, 2018 .

An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS

J. Kanis, M. Jürisson, E. McCloskey, 2022, Quality of Life Research.

Skeletal Response to Dietary Zinc in Adult Female Mice

H. Dimai, J. Farley, S. Hall, 1998, Calcified Tissue International.

The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture

S. Silverman, J. Kanis, M. Jürisson, 2013, Osteoporosis International.

Cost-utility analysis of fracture risk assessment using microRNAs compared with standard tools and no monitoring in the Austrian female population.

H. Dellago, J. Grillari, M. Hackl, 2018, Bone.

Effect of vitamin D3 on bone turnover markers in critical illness: post hoc analysis from the VITdAL-ICU study

T. Pieber, B. Obermayer-Pietsch, V. Schwetz, 2017, Osteoporosis International.

Use of proton pump inhibitors and mortality after hip fracture in a nationwide study

J. Zwerina, H. Dimai, K. Klaushofer, 2017, Osteoporosis International.

Mortality After Hip Fracture in Austria 2008–2011

J. Zwerina, D. Kritsch, O. Kimberger, 2014, Calcified Tissue International.

Fracture risk and zoledronic acid therapy in men with osteoporosis.

J. Reginster, R. Rizzoli, S. Boonen, 2012, The New England journal of medicine.

Ibandronate and Calcitriol Reduces Fracture Risk, Reverses Bone Loss, and Normalizes Bone Turnover After lTX

P. Kornprat, T. Pieber, K. Tscheliessnigg, 2012, Transplantation.

Epidemiology of proximal humeral fractures in Austria between 1989 and 2008

T. Pieber, H. Resch, H. Dimai, 2013, Osteoporosis International.

Measurements of circulating ionized magnesium level: fresh whole blood samples versus serum samples.

K. Lau, H. Dimai, G. Wirnsberger, 2000, Clinical biochemistry.

Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities.

L. Donahue, S. Mohan, C. Rosen, 1997, Bone.

Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS

S. Silverman, J. Kanis, M. Jürisson, 2018, Osteoporosis International.

Assessing the effects of long-term osteoporosis treatment by using conventional spine radiographs: results from a pilot study in a sub-cohort of a large randomized controlled trial

H. Dimai, A. Fahrleitner-Pammer, S. Nehrer, 2018, Skeletal Radiology.

Mind the gap: Incidence of osteoporosis treatment after an osteoporotic fracture - Results of the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).

H. Dimai, A. Fahrleitner-Pammer, A. Svedbom, 2019, Bone.

New and Emerging Therapies for Osteoporosis

J. Reginster, M. Brandi, B. Williams, 2010, Journal of osteoporosis.

Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease

B. Obermayer-Pietsch, G. Leb, H. Dimai, 2005, Osteoporosis International.

Hyperthyroidism of Graves’ disease: Evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient

R. Lipp, G. Leb, H. Dimai, 1999, Journal of endocrinological investigation.

Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment; WHO-criteria, T- and Z-score, and reference databases.

H. Dimai, Hans P. Dimai, 2017, Bone.

Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS

S. Silverman, J. Kanis, M. Jürisson, 2018, Quality of Life Research.

Time: an underestimated variable in minimizing the gender gap in medical college admission scores

G. Reibnegger, H. Dimai, D. Ithaler, 2015, Wiener klinische Wochenschrift.

Osteoprotegerin serum levels in women: Correlation with age, bone mass, bone turnover and fracture status

C. Bonelli, B. Obermayer-Pietsch, G. Leb, 2003, Wiener Klinische Wochenschrift.

Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group

M. Hiligsmann, O. Bruyère, P. Lips, 2022, Archives of Osteoporosis.

The role of calcium supplementation in healthy musculoskeletal ageing

C. Cooper, J. Reginster, O. Bruyère, 2017, Osteoporosis International.

Letter to the Editor: Preadmission Bisphosphonate and Mortality in Critically Ill Patients.

H. Dimai, K. Amrein, S. Perl, 2016, The Journal of clinical endocrinology and metabolism.

Situational judgment test as an additional tool in a medical admission test: an observational investigation

G. Reibnegger, H. Dimai, D. Ithaler, 2015, BMC Research Notes.

Bone Research Society, Annual Meeting 2017 Proceedings

P. Tsai, T. Spector, J. Bell, 2018, Journal of musculoskeletal & neuronal interactions.

New Horizons: Artificial Intelligence Tools for Managing Osteoporosis

H. Dimai, 2022, The Journal of Clinical Endocrinology and Metabolism.

Official Positions for FRAX® clinical regarding smoking from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

H. Dimai, M. Chandran, 2011, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Diagnostik der Osteoporose

H. Dimai, 2009, Wiener Medizinische Wochenschrift.

H. Dimai, E. Boschitsch, E. Durchschlag, 2017, Climacteric : the journal of the International Menopause Society.

Higher dose but not low dose proton pump inhibitors are associated with increased risk of subsequent hip fractures after first hip fracture: A nationwide observational cohort study

J. Zwerina, H. Dimai, K. Klaushofer, 2019, Bone reports.

Ibandronate Prevents Bone Loss and Reduces Vertebral Fracture Risk in Male Cardiac Transplant Patients: A Randomized Double‐Blind, Placebo‐Controlled Trial

T. Pieber, K. Tscheliessnigg, S. Pilz, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

How Long Should Women with Postmenopausal Osteoporosis be Treated with a Bisphosphonate?

R. Gasser, P. Pietschmann, B. Obermayer-Pietsch, 2013, Hormone and Metabolic Research.

[Guidelines for drug therapy of postmenopausal osteoporosis].

P. Pietschmann, G. Leb, H. Resch, 2002, Wiener medizinische Wochenschrift.

Biomarkers of bone turnover in diagnosis and therapy of osteoporosis

A. Griesmacher, R. Gasser, C. Bieglmayer, 2012, Wiener Medizinische Wochenschrift.

The effect of PTH(1–84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial

H. Dimai, J. Gómez-Reino, C. Muschitz, 2011, Osteoporosis International.

The discriminatory capacity of BMD measurements by DXA and dual X-ray and laser (DXL) at the calcaneus including clinical risk factors for detecting patients with vertebral fractures

A. Kaider, H. Resch, H. Dimai, 2013, Osteoporosis International.

Inter-observer agreement of vertebral fracture assessment with dual-energy x-ray absorptiometry equipment

P. Dibbets-Schneider, H. Dimai, D. Rietbergen, 2021, Archives of Osteoporosis.

Epidemiology and Economic Burden of Osteoporosis in Austria A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)

C. Cooper, J. Kanis, E. McCloskey, 2013 .

Clinicians should be aware of their responsibilities as role models: a case report on the impact of poor role modeling.

H. Dimai, L. Mileder, A. Schmidt, 2014 .

Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report

H. Dimai, A. Fahrleitner-Pammer, K. Amrein, 2016, Osteoporosis International.

The Impact of Lockdown during COVID-19 Pandemic on Hip Fracture Cases in Austria

H. Dimai, M. Oliver, Brozek Wolfgang, 2021 .

Epidemiology of major lower extremity amputations in individuals with diabetes in Austria, 2014-2017: A retrospective analysis of Health Insurance database.

M. Brodmann, H. Sourij, D. Reichart, 2020, Diabetes research and clinical practice.

Have “new” methods in medical education reached German-speaking Central Europe: a survey

H. Dimai, Marion Habersack, Martin Fandler, 2014, BMC medical education.

Epidemiology of hip fractures in Austria: evidence for a change in the secular trend

T. Pieber, H. Resch, H. Dimai, 2011, Osteoporosis International.

Economic burden of osteoporotic fractures in Austria

U. Siebert, J. Mahlich, K. Redlich, 2012, Health Economics Review.

The effect of RANKL and OPG on bone mineral density in pre-dialysis chronic renal failure.

H. Holzer, H. Dimai, A. Fahrleitner-Pammer, 2009, Clinical Nephrology.

Langfristige Therapiekonzepte bei Osteoporose

B. Obermayer-Pietsch, H. Dimai, Ines Fößl, 2021, Der Internist.

Gene Expression and Bone Architecture in Men with Osteoporotic Hip Fractures

A. Tomaschitz, G. Watzek, H. Dimai, 2019 .

Successful antibiotic treatment of Borreliosis associated pseudolymphomatous systemic infiltrates.

L. Cerroni, C. Wenisch, H. Dimai, 2005, The Journal of infection.

Epidemiology and economic burden of fragility fractures in Austria

J. Grillari, H. Dimai, C. Muschitz, 2021, Osteoporosis International.

Long-term and sequential treatment for osteoporosis

B. Obermayer-Pietsch, H. Dimai, I. Foessl, 2023, Nature Reviews Endocrinology.

Methodology to predict thresholds for loading corridors of human ribs

W. Sinz, H. Steffan, J. Patsch, 2010 .

Clinicians should be aware of their responsibilities as role models: a case report on the impact of poor role modeling

H. Dimai, L. Mileder, A. Schmidt, 2014, Medical education online.

Diagnose und Therapie der Osteoporose bei Patienten mit chronischer Niereninsuffizienz

H. Dimai, A. Fahrleitner-Pammer, K. Amrein, 2022, Wiener Medizinische Wochenschrift.

Testosterone replacement has a substantial benefit on bone mass, fracture incidence, libido, and sexual activities in male cardiac transplant patients: a 5-year randomized prospective controlled trial

T. Pieber, S. Pilz, D. Wagner, 2013 .

Exercise increases plasma concentrations of (R)- and (S)-propranolol

G. Krejs, K. Stoschitzky, W. Lindner, 1996, European Journal of Clinical Pharmacology.

New considerations on the management of osteoporosis in Central and Eastern Europe (CEE): summary of the “3rd Summit on Osteoporosis—CEE”, November 2009, Budapest, Hungary

D. Hans, P. Lakatos, B. Obermayer-Pietsch, 2011, Archives of osteoporosis.

Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.

T. Pieber, K. Pfeifer, A. Tomaschitz, 2012, The Journal of clinical endocrinology and metabolism.

Combining fractal- and entropy-based bone texture analysis for the prediction of Osteoarthritis: data from the Multicenter Osteoarthritis study (MOST)

H. Dimai, R. Ljuhar, D. Ljuhar, 2018, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.